about
Rheumatoid arthritis in patients with HIV: management challengesEvolutionary medicine and bone loss in chronic inflammatory diseases--A theory of inflammation-related osteopeniaBiologic therapies and bone loss in rheumatoid arthritis.Herpes zoster as a risk factor for osteoporosis: A 15-year nationwide population-based study.Rheumatoid arthritis with deficiency pattern in traditional chinese medicine shows correlation with cold and hot patterns in gene expression profilesTh17 and Treg cells in bone related diseases.Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.Osteoarthritis and osteoporosis: what is the overlap?Effects of obesity on function and quality of life in chronic pain conditions.The intelligent use of systemic glucocorticoids in rheumatoid arthritis.Chronic inflammatory diseases: do immunological patterns drive the choice of biotechnology drugs? A critical review.Management of osteoporosis in rheumatoid arthritis patients.Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area.Prevalence and possible risk factors of low bone mineral density in untreated female patients with systemic lupus erythematosus.Ankylosing spondylitis is associated with an increased risk of vertebral and nonvertebral clinical fractures: a population-based cohort study.Prevalence and predictors of low bone density and fragility fractures in women with systemic lupus erythematosus in a Mediterranean region.The Role of Autoantibodies in Bone Metabolism and Bone Loss.Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity.Short-term daily teriparatide in patients with rheumatoid arthritis.Role of Vitamin D in Rheumatoid Arthritis.Clinical utilities of quantitative ultrasound in osteoporosis associated with inflammatory rheumatic diseases.The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates.
P2860
Q28075624-A5A47C05-E575-4399-98BA-C14E0A3EC8EDQ28088695-FBCBE937-DB94-4AA8-BA59-913F56EE9EEEQ30243911-A7B54415-A80E-4C28-AB91-84C1DD3D3566Q37205158-51F1D2C4-0C5C-49D4-BC9F-A46A6EE937E0Q37224843-9C3E7199-2C1B-4A8E-B091-0BE3F82634D6Q37239790-8D9369F6-7A97-467B-B4A7-A254F49B0D55Q38073889-FA824C7F-D8DF-42CB-A3C5-76AA73914AA4Q38091012-F72C60C3-6665-4BEE-A037-0CDE0171F8E1Q38165093-222F3BCB-4126-4363-958F-80274B5D4745Q38168952-C47551D5-E0DA-43E5-BA03-429B9E57CC7BQ38201788-6B59A33C-A239-4EFB-BAF9-636DDD883565Q38334318-0D64AF4C-4089-4906-9036-C2C937267B7EQ40282583-2933B9C2-5C60-4491-9D66-2FE20F22D14AQ42073555-939958A2-E1BA-4545-86C4-B66E4EC81B1CQ45250384-2D866F72-9B82-4A23-B5CF-80A610C84A9BQ45418265-3E351CB2-33AD-48C5-8D46-63CFD3545B9AQ47331159-2F22E0CD-C9E4-4E73-AF34-91793A927AD4Q47831537-2D226FDD-A807-4D5C-9660-9F1E97C95128Q48694023-5409A0A9-1AB3-4E5C-8B90-2F188ED6D193Q50074946-F2C6DBA2-A48B-4E46-9B5D-510083254830Q51763026-F9FDB107-AC7C-4868-8006-10B44E73B9C2Q52584217-FF9AD3EA-6E51-421B-B4B9-20C908FCE394
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Inflammatory rheumatic disorders and bone.
@ast
Inflammatory rheumatic disorders and bone.
@en
type
label
Inflammatory rheumatic disorders and bone.
@ast
Inflammatory rheumatic disorders and bone.
@en
prefLabel
Inflammatory rheumatic disorders and bone.
@ast
Inflammatory rheumatic disorders and bone.
@en
P2093
P2860
P1476
Inflammatory rheumatic disorders and bone.
@en
P2093
Irene E M Bultink
Marijn Vis
Willem F Lems
P2860
P2888
P304
P356
10.1007/S11926-012-0252-8
P577
2012-06-01T00:00:00Z